Asm Iskander
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Mesenchymal stem cell research
-
- Circadian rhythm and melatonin
Papers in
-
- Angiogenesis and VEGF in Cancer 10
- Genetics 17
- Glioma Diagnosis and Treatment 15
- Mesenchymal stem cell research 3
- Virus-based gene therapy research 3
- Co-authors
- Ali S. Arbab (35 shared papers)Adarsh Shankar (19 shared papers)Branislava Janic (15 shared papers)Thaiz F. Borin (15 shared papers)Meser M. Ali (11 shared papers)Nadimpalli R. S. Varma (10 shared papers)Ali M. Rad (6 shared papers)Hamid Soltanian‐Zadeh (7 shared papers)
- Journals
- PLoS ONE (11 papers)Cancer Research (4 papers)Scientific Reports (2 papers)Journal of Magnetic Resonance Imaging (2 papers)Journal of Pineal Research (1 paper)
- Partner nations
- United StatesBrazilIran
In The Last Decade
Asm Iskander
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 117
- Genetics 280
- Endocrine and Autonomic Systems 160
- Cancer Research 270
- Immunology 206
- Biomaterials 125
Countries citing papers authored by Asm Iskander
This map shows the geographic impact of Asm Iskander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asm Iskander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asm Iskander more than expected).
Fields of papers citing papers by Asm Iskander
This network shows the impact of papers produced by Asm Iskander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asm Iskander. The network helps show where Asm Iskander may publish in the future.
Co-authors
The 25 scholars most cited alongside Asm Iskander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 164 | |
| 2 | 2015 | 110 | |
| 3 | 2007 | 84 | |
| 4 | 2010 | 64 | |
| 5 | 2007 | 56 | |
| 6 | 2018 | 55 | |
| 7 | 2009 | 46 | |
| 8 | 2010 | 45 | |
| 9 | 2013 | 42 | |
| 10 | 2017 | 42 | |
| 11 | 2015 | 41 | |
| 12 | 2013 | 36 | |
| 13 | 2014 | 35 | |
| 14 | 2015 | 35 | |
| 15 | 2017 | 35 | |
| 16 | 2013 | 31 | |
| 17 | 2012 | 25 | |
| 18 | 2009 | 25 | |
| 19 | 2008 | 23 | |
| 20 | 2017 | 22 |
About Asm Iskander
Asm Iskander is a scholar working on Molecular Biology, Genetics, Cancer Research, Immunology and Oncology, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Cancer, Hypoxia, and Metabolism (12 papers), Angiogenesis and VEGF in Cancer (10 papers), Immune cells in cancer (10 papers), Chemokine receptors and signaling (3 papers), Mesenchymal stem cell research (3 papers), Virus-based gene therapy research (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Genetics (280 citations), Endocrine and Autonomic Systems (160 citations), Cancer Research (270 citations), Immunology (206 citations) and Biomaterials (125 citations). Asm Iskander has collaborated with scholars based in United States, Brazil and Iran. Frequent co-authors include Ali S. Arbab, Adarsh Shankar, Branislava Janic, Thaiz F. Borin, Meser M. Ali, Nadimpalli R. S. Varma, Ali M. Rad, Hamid Soltanian‐Zadeh, Bruna V. Jardim‐Perassi and Nadimpalli Ravi S. Varma. Their work appears in journals such as PLoS ONE, Cancer Research, Scientific Reports, Journal of Magnetic Resonance Imaging and Journal of Pineal Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.